PharmacyCodes



Zopiclona [Inn-Spanish] en es it fr

Zopiclona [Inn-Spanish] Brand names, Zopiclona [Inn-Spanish] Analogs

Zopiclona [Inn-Spanish] Brand Names Mixture

  • No information avaliable

Zopiclona [Inn-Spanish] Chemical_Formula

C17H17ClN6O3

Zopiclona [Inn-Spanish] RX_link

No information avaliable

Zopiclona [Inn-Spanish] fda sheet

Zopiclona [Inn-Spanish] msds (material safety sheet)

Zopiclona [Inn-Spanish] Synthesis Reference

No information avaliable

Zopiclona [Inn-Spanish] Molecular Weight

388.808 g/mol

Zopiclona [Inn-Spanish] Melting Point

178 oC

Zopiclona [Inn-Spanish] H2O Solubility

No information avaliable

Zopiclona [Inn-Spanish] State

Solid

Zopiclona [Inn-Spanish] LogP

-0.88

Zopiclona [Inn-Spanish] Dosage Forms

Tablet

Zopiclona [Inn-Spanish] Indication

For the short-term treatment of insomnia.

Zopiclona [Inn-Spanish] Pharmacology

Zopiclone is a nonbenzodiazepine hypnotic from the pyrazolopyrimidine class and is indicated for the short-term treatment of insomnia. While Zopiclone is a hypnotic agent with a chemical structure unrelated to benzodiazepines, barbiturates, or other drugs with known hypnotic properties, it interacts with the gamma-aminobutyric acid-benzodiazepine (GABABZ) receptor complex. Subunit modulation of the GABABZ receptor chloride channel macromolecular complex is hypothesized to be responsible for some of the pharmacological properties of benzodiazepines, which include sedative, anxiolytic, muscle relaxant, and anticonvulsive effects in animal models. Zopiclone binds selectively to the brain alpha subunit of the GABA A omega-1 receptor.

Zopiclona [Inn-Spanish] Absorption

No information avaliable

Zopiclona [Inn-Spanish] side effects and Toxicity

No information avaliable

Zopiclona [Inn-Spanish] Patient Information

No information avaliable

Zopiclona [Inn-Spanish] Organisms Affected

Humans and other mammals